Pro12Ala Polymorphism of the PPARγ2 Gene Interacts With a Mediterranean Diet to Prevent Telomere Shortening in the PREDIMED-NAVARRA Randomized Trial

被引:40
|
作者
Garcia-Calzon, Sonia [1 ]
Martinez-Gonzalez, Miguel A. [2 ,5 ]
Razquin, Cristina [2 ]
Corella, Dolores [5 ,6 ]
Salas-Salvado, Jordi [5 ,7 ]
Alfredo Martinez, J. [1 ,3 ,5 ]
Zalba, Guillermo [4 ]
Marti, Amelia [1 ,5 ]
机构
[1] Univ Navarra, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain
[2] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain
[3] Univ Navarra, Ctr Nutr Res, E-31080 Pamplona, Spain
[4] Univ Navarra, Dept Biochem & Genet, E-31080 Pamplona, Spain
[5] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain
[6] Univ Valencia, Dept Prevent Med & Publ Hlth, E-46003 Valencia, Spain
[7] Univ Rovira & Virgili, Dept Human Nutr, Hosp Univ St Joan, Inst Invest Sanitaria Pere Virgili, E-43201 Reus, Spain
关键词
diet; genetic polymorphism; nutrigenomics; telomere; PHYSICAL-ACTIVITY QUESTIONNAIRE; GENDER-SPECIFIC ASSOCIATION; CARDIOVASCULAR-DISEASE; COMMON VARIANTS; LIFE-STYLE; FOLLOW-UP; LENGTH; RISK; VALIDATION; INCREASES;
D O I
10.1161/CIRCGENETICS.114.000635
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The gene variant Pro/Ala (rs1801282) in the PPAR gamma 2 has been associated with lower cardiovascular risk and greater benefit from lifestyle interventions. This polymorphism also seems to be associated with longer lifespan, but no information on telomere length (TL) is available. Our aim was to study the association between the Ala allele and changes in TL in high cardiovascular risk subjects and the potential interaction with a Mediterranean dietary pattern. Methods and Results-A total of 521 subjects (55-80 years) participating in the Prevencion con Dieta Mediterranea randomized trial were genotyped. Changes in TL, measured by quantitative real-time polymerase chain reaction (PCR), were assessed over 5 years of a nutritional intervention, which promoted adherence to the Mediterranean diet (MeDiet). Interestingly, Ala carriers showed lower telomere shortening after 5 years compared with the Pro/Pro genotype (P=0.031). This association was modulated by MeDiet because those Ala carriers who reported better conformity to the MeDiet exhibited increased TL (P<0.001). Moreover, a reduction in carbohydrate intake (<= 9.5 g/d) resulted in increased TL among Ala carriers. Notably, an apparent gene-diet interaction was found through the observed changes in the MUFA+PUFA/carbohydrates ratio: as this ratio increased, TL lengthening was detected to a greater extent in the Ala carriers compared with the Pro/Pro subjects (P for interaction <0.001). Conclusions-The Pro12Ala polymorphism is associated with TL homeostasis after 5 years follow-up in subjects at high cardiovascular risk. In addition, a higher adherence to the MeDiet pattern strengthens the prevention of telomere shortening among Ala carriers.
引用
收藏
页码:91 / U171
页数:11
相关论文
共 50 条
  • [21] Does Pro12Ala Polymorphism Enhance the Physiological Role of PPARγ2?
    Pereira, A. C.
    Oliveira, R.
    Castro, A. C.
    Fernandes, R.
    PPAR RESEARCH, 2013, 2013
  • [22] Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome
    Bozena Bidzinska-Speichert
    Agnieszka Lenarcik
    Urszula Tworowska-Bardzinska
    Ryszard Slezak
    Grazyna Bednarek-Tupikowska
    Andrzej Milewicz
    Katarzyna Krepula
    Ginekol Pol
    GINEKOLOGIA POLSKA, 2011, 82 (06) : 426 - 429
  • [23] Pro12Ala polymorphism of the PPAR-γ2 gene and the metabolic syndrome. Preliminary study
    Fernandez, Erika
    Marina Morales, Luz
    Vargas, Renata
    Sandrea, Laury
    Molero-Conejo, Emperatriz
    Fernandez, Virginia
    Zambrano, Mariana
    Connell, Lissett
    Campos, Gilberto
    Aranguren-Mendez, Jose
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2009, 43 (01): : 3 - 9
  • [24] Olanzapine-induced weight gain and the Pro12Ala polymorphism of the PPAR-γ2 gene
    Mueller, Daniel J.
    Sturgess, Jessica E.
    PHARMACOGENOMICS, 2009, 10 (11) : 1737 - 1738
  • [25] Effect of the Pro12Ala polymorphism of the PPARγ2 gene on response to pioglitazone treatment in menopausal women
    Ramirez-Salazar, Monica
    Perez-Luque, Elva
    Fajardo-Araujo, Martha
    Martinez Garza, Sandra
    Manuel Malacara, Juan
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1151 - 1156
  • [26] Pro12Ala PPARγ2 gene polymorphism in PCOS women: the role of compounds regulating satiety
    Bidzinska-Speichert, Bozena
    Lenarcik, Agnieszka
    Tworowska-Bardzinska, Urszula
    Slezak, Ryszard
    Bednarek-Tupikowska, Grazyna
    Milewicz, Andrzej
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (03) : 195 - 198
  • [27] The Pro12Ala polymorphism of PPARγ gene and susceptibility to type 2 diabetes mellitus in a polish population
    Klupa, T
    Frey, J
    Malecki, M
    Skupien, J
    Walus, M
    Sieradzki, J
    DIABETES, 2003, 52 : A512 - A512
  • [28] The metabolic effects of the Pro12Ala Polymorphism of the PPAR gamma 2 gene interact with size at birth
    Eriksson, JG
    Lindi, V
    Uusitupa, M
    Forsen, T
    Laakso, M
    Osmond, C
    Barker, D
    DIABETOLOGIA, 2002, 45 : A125 - A126
  • [29] Quantitative evaluation of PPAR-γ2 Pro12Ala polymorphism with hypertension; [Quantitative Auswertung des PPAR-γ2 Pro12Ala Polymorphismus bei Hypertonie]
    Yang W.
    Wang J.
    Ye W.
    Li X.
    Herz, 2018, 43 (8) : 719 - 727
  • [30] The Pro12Ala polymorphism of PPARγ2 gene and susceptibility to type 2 diabetes mellitus in a Polish population
    Malecki, MT
    Frey, J
    Klupa, T
    Skupien, J
    Walus, M
    Mlynarski, W
    Sieradzki, J
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 62 (02) : 105 - 111